בליאומיצין PFI

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

BLEOMYCIN SULFATE

Tilgængelig fra:

MEGAPHARM LTD

ATC-kode:

L01DC01

Lægemiddelform:

אבקה להכנת תמיסה לזריקה

Sammensætning:

BLEOMYCIN SULFATE 15000 IU/VIAL

Indgivelsesvej:

לתוך קרום הריאה, תוך-עורקי, תוך-ורידי, תת-עורי, תוך-שרירי, לתוך בקע

Recept type:

מרשם נדרש

Fremstillet af:

BAXTER ONCOLOGY GmbH, GERMANY

Terapeutisk gruppe:

BLEOMYCIN

Terapeutisk område:

BLEOMYCIN

Terapeutiske indikationer:

Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

Autorisation dato:

2020-09-30